Publications Digest

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Aballéa et al. critically reviewed the EU HTA Coordination Group guidelines on direct and indirect treatment comparisons in the context of joint clinical assessments.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Bralić et al. conducted a scoping review of methodologies for generating and evaluating evidence for high-risk and innovative medical devices and in vitro diagnostics in the EU.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, de la Cuadra-Grande et al. developed a methodological framework for interpreting indirect treatment comparisons within the European Joint Clinical Assessment process under the Health Technology Assessment Regulation.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Bujkiewicz et al. developed an ISPOR Task Force good-practice report on methods for evaluating surrogate endpoints in health technology assessment decision-making.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Sarri et al. mapped the role of real-world evidence within the EU Health Technology Assessment Regulation, examining its methodological applications in EU joint clinical assessments.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Godoy Junior et al. systematically reviewed health economic evaluations of medical artificial intelligence technologies to assess their reporting quality, methodological risk of bias, and technological maturity.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Ursino et al. proposed a statistical framework for evaluating digital medical devices under European fast-track HTA pathways, where temporary access and reimbursement may be granted despite incomplete clinical evidence.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Meregaglia et al. explored the expected impact of implementing the EU HTA Regulation and Joint Clinical Assessment through a multi-stakeholder case study in Italy.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Pisavadia et al. examined the economic value of clinical registries through a systematic scoping review of economic evaluations, costing studies, and grey literature.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Haon et al. mapped early and accelerated access pathways for medical devices across the 27 EU Member States to clarify how patients may receive devices before full routine market access in situations of unmet need.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Xander et al. examined the legal implications of Joint Clinical Assessments under the EU HTA Regulation, focusing on PICO disparities across Member States and conflict-of-interest management in expert involvement.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, DiModica et al. explored the role of patient-reported outcomes in HTA decision-making across England, France, and Germany.